Gel chromatography o f normal human serum e x h i b i t s a low mol e c u l a r weight f r a c t i o n , which s i g n i f i c a n t l y i n h i b i t s t h e act i o n o f somatomedin on porcine r i b c a r t i l a g e segments. This somatomedin i n h i b i t o r y f r a c t i o n (SmIF) has a molecular weight o f about 1250 daltons, an i s o -e l e c t r i c p o i n t between 5 t o 5.5 and shows several c h a r a c t e r i s t i c s o f a peptide nature (Ped. Res. 18:lO ,1984 ).
This SmIF s t r o n g l y reduces both 3 5~-s u lphate and jH-Thymidine incorpo a t i o n i n t o costal c a r t i l a g e o f young p i g s and r a b b i t s and 3SS-sulphate uptake by embryonic c h i c k c a r t i l a g e .
This e f f e c t i s dose-dependent, both i n basal and i n serum stimulated conditions, and i s r e v e r s i b e.
To a s i m i l a r extent, SmIF decreases t h e conversion o f 14C-glucose i n t o 14c02 i n epididymal f a t pads o f young r a t s , w i t h o r w i t h o u t a d d i t i o n o f normal serum, i n s u l i n o r t r i i o d o t h y r o n i n e . I n conclusion, t h i s low molecular weight SmIF does n o t o n l y i n h i b i t s p e c i f i c a l l y t h e i n v i t r o a c t i o n o f somatomedin on cart i l a g e o f several animal species, b u t a l s o counteracts t h e i n s u l i n -l i k e a c t i v i t y o f normal serum and t h e e f f e c t o f i n s u l i n and t r i i o d o t h y r o n i n e on glucose metabolism o f r a t adipose t i ssue.
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Nerve growth f a c t o r (NGF) and epidermal growth f a c t o r (EGF) a r e present i n mouse m i l k d u r i n g e a r l y l a c t a t i o n NGF i s important f o r t h e d i f f e r e n t i a t i o n and maintenance o f t h e sympathetic nervous system and EGF promotes e y e l i d opening, t o o t h e r u p t i o n and maturation o f t h e i n t e s t i n e i n newborn mice. Both growth f a c t o r s a r e present i n h i g h concentrations i n mouse submandibular gland (SMG) and d i s t r i b u t e d i n l e s s e r amounts i n many mouse and human body f l u i d s and tissues. The present study was conducted
t o prove t h e b i o l o g i c a l a c t i v i t y o f milk-NGF and t o c h a r a c t e r i z e t h e ontogeny o f NGF and EGF and molecular p r o f i l e o f EGF i n e a r l y l a c t a t i o n i n normal and sialoadenoectomized mice t o determine whether t h e SMG c o n t r i b u t e s s i g n i f i c a n t l y t o m i l k growth f a c t o r s . Concentrations o f NGF, determined by RIA, d i d n o t
change from day 1 t o day 9 o f l a c t a t i o n (600 pg/mg p r o t e i n ) and were n o t d i f f e r e n t i n sialoadenoectomized mice. B i o l o g i c a l a c t i v i t y was proven by PC-12 bioassay a f t e r p a r t i a l p u r i f i c a t i o n . EGF showed o n l y one component, s i m i l a r t o SMG-EGF ( MW 6045), i n gel exclusion chromatography, b u t removal o f t h e SMG d i d n o t change t h e concentration which peaked around day 6 o f l a c t a t i o n ( l o ng/mg p r o t e i n ) . Conclusion: Growth f a c t o r s a r e present i n s i g n i f i c a n t concentrations i n mouse m i l k and t h e SMG i s n o t t h e i r o r i g i n .
J.L. CHWSSAIN, M. COLLE, P.F. BOUGNERES, J.E. TOUBLIWC. Hdpital Saint Vincent de Paul, 37 Paris, France.
Fasting blood glucose (BG) concentration long before the onset of insulin-dependent diabetes melitus (IDDM) in children.
Among several hundred children with IDDM, 22 had a fasting BG fortituously measured 5 years to 6 months prior to the clinical onset of the disease, because of intercurrent illness or minor surgery. Fasting BG averaged 107 2 27 mg/dl (SD) VS 79 2 09 mg/dl in controls studied in similar conditions (p< 0.001), with a wide range of values from 53 to 152 mg/dl in patients. Among them 16 (77%) had fasting BG over 106 mg/dl, with a delay to the diagnosis of IDDM ranging from 5 years to 6 months. All of them were asymptomatic and had no familial history of IDDM. Abnormal BG (> 200 mg/dl) and insulin (< 30 pg/ml) responses were documented in 4 of them during an OGTT. These data, rarely available in children with IDDM, indicate that the clinical onset of the disease may be preceeded by a long period o,f minor hyperglycemia and hypoinsulinism. At the time when the efficiency of immunosuppressive therapies at the very onset of IDDM is under investigation, a systematic screening of BG in children may proove useful.
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L~n g i t~d i~l study of cytotoxic antibodies and inhibitory lyqkcytes i n 7 diabetic children during the first year of their disease.
To investigate the possible role of autoimmune phenomenons during the remission period in type I diabetes, we have studied the time-course of two immunological markers in 7 diabetic children (age:1.5-7 y). During 12 months following diagnosis, we determined: 1)cytotoxic islet cells antibodies(C1CA) by the release of 5 1~~ from mice islet cells after complement fixati0n;Z)inhibitory lymphocytes(1L)tested by the inhibition of mice islet cells insulin secretion after patients lymphocytes addition. All the children have been treated by highly purified pork insulin. 5/7 children* derwent a remission period (insulin requirements<0.5 U/kg/d) within the first weeks of treatment. CICA were found positive in 85% of the children at the time of diagnosis, and were decreasingafter 6 months of disease(lO% of positive sera at 12 months).CICA titration was not static in a same patient. IL were found in 85% of the children at the onset and remained elevated,(80% at 12 months)despite a slight decrease after 6 months of disease. No correlation was found between insulin requirements and immunologicalplram~s. In conclusion :-CICA were present in diabetic children with a high frequency early after diagnosis, which was decreasing after 6 months. -1L were present as well early after diagnosis. They a p h red to be more stable during the first year of disease. E-SCHOBER,' H.FRISCH, G.SCHERNTHANER,+ M.BOR-KENSTEIN.+ Ped-Dept., 2.Med.Dept., LBI Ped. Endocrinology, Univ.Vienna, Ped.Dept.Univ. 51 diabetic children (mean age 15,5+2,0 years) were exclusively treated with semisynthetic human insulin (HI) since manifestation of the disease. Insulin-antibodies (Iab), HbAl and stimulated C-peptide levels (l2Omin. after standard breakfast) were determined before and 2-12 months after HI-treatment. After l 2 m t h s therapy 32 patients were Iab negative (group A) while 19 patients developed low Iab titres (group B). There was no difference in the HbAl values between the two groups. Stimulated C-peptide secretion was significantly higher in group A (0,18+0,02 vs 0,12+0,02pmol/ml, p-0,025). Daily insulin requirement was significantly lower in group A (0,39+0,05 vs 0,61+0,11 IU/kg b.w., p-0,025) after one year treatment. This finding indicates that the Iab negative condition is associated with preservation of endogenous B-cell secretion and lower exogenous insulin requirement. 
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Growth hormone therapy following intracranial neoplasia: the final outcome The final height of 27 children who developed growth hormone (GH) deficiency following treatment of an intracranial neoplasm (excluding craniopharyngioma) was studied. Eighteen children had tumours of the hypothalamo-pituitary tract, all but one of these had additional trophic hormone deficiencies. Nine children had other intracranial tumours, seven of these had isolated GH deficiency. Tvrelve patients finished with a height above the third centile for the population, but none fulfilled their genetic potential for stature. Sitting height was disproportionately reduced in all patients, this being even more pronounced in those with GH and gonadotrophin (Gn) deficiency. Patients with hypothalamo-pituitary tumours or those with GH and Gn deficiency showed significantly greater rise in height standard deviation score following therapy (p<0.005) than those with other cranial tumours or those who underwent spontaneous puberty. This was due largely to improved spinal growth. Sex of the patients and spinal irradiation were not significant factors in the overall response to therapy. It is postulated that cranial irradiation sufficient to cause GH deficiency may induce partial Gn deficiency in which sexual maturation occurs but the full effect of the pubertal spinal growth is not experienced
